Improving timing of early neonatal hypoglycemia screening in the well-baby nursery
Related Experiment Video
Updated: Jan 12, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Kelechi Ikeri1, Vicki Curtis2, Anna Bozeman2
1Divisions of Neonatology, University of South Alabama Children's and Women's Hospital, Mobile, AL, USA. kcikeri@health.southalabama.edu.
Insights
Improving neonatal glucose screening timing is crucial for preventing neurodevelopmental issues. This study enhanced early detection of neonatal hypoglycemia without affecting breastfeeding rates.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Clinical Quality Improvement
Background:
- Neonatal hypoglycemia poses risks to neurodevelopment.
- Early detection via glucose screening is vital, per AAP guidelines.
- Optimizing screening timing is a key clinical objective.
Purpose of the Study:
- To improve the timeliness of neonatal glucose screening.
- To ensure screening improvements do not negatively impact breastfeeding.
- To enhance adherence to institutional hypoglycemia screening protocols.
Main Methods:
- Initiative conducted from November 2021 to April 2023.
- Focused on timely recognition of at-risk infants.
- Emphasized improved adherence to institutional screening protocols.
Main Results:
- Mean age at initial glucose screening decreased by 37% (175 to 111 min).
- Median age at hypoglycemia detection reduced significantly (133 to 101 min).
- Late-detected hypoglycemia episodes decreased from 30% to 0%; breastfeeding rates remained stable.
Conclusions:
- Early risk factor recognition and staff education improve screening timing.
- Enhanced team handoffs are critical for timely hypoglycemia detection.
- Improvements in screening timing can be achieved without compromising breastfeeding or increasing maternal-infant separation.
Background:
Neonatal hypoglycemia can impair neurodevelopment. Timely glucose screening, aligned with AAP guidelines, may enable prompt detection of hypoglycemia.
Methods:
This initiative, conducted from November 2021 to April 2023, aimed to improve the timing of screening without negatively impacting breastfeeding. Key drivers included timely recognition of at-risk status and improved adherence to the institutional protocol.
Results:
Overall, 823 infants were screened. Mean age at initial glucose screening decreased by 37%, from 175 to 111 min (p < 0.001). Median (IQR) age at hypoglycemia detection reduced from 133 (107-180) to 101 (81-118) minutes (p < 0.001). Late-detected hypoglycemia episodes (detected >2 h of age) among affected infants decreased from 30 to 0% (p = 0.06). Exclusive breastfeeding and NICU transfer rates for hypoglycemia remained stable.
Conclusions:
Early recognition of risk factors, staff education, and improved team handoffs can improve timing of initial hypoglycemia screening without impacting breastfeeding or increasing maternal-infant separation.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

